We serve Chemical Name:2-(pyrrolidin-1-yl)-1-p-tolylhexan-1-one CAS:34138-58-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(pyrrolidin-1-yl)-1-p-tolylhexan-1-one
CAS.NO:34138-58-4
Synonyms:4′-Methyl-α-pyrrolidinohexiophenone;1-(4-Methylphenyl)-2-(1-pyrrolidinyl)-1-hexanon;UNII:Y8D4922F5K;1-Hexanone, 1-(4-methylphenyl)-2-(1-pyrrolidinyl)-;1-(4-Methylphenyl)-2-(1-pyrrolidinyl)-1-hexanone;2-(pyrrolidin-1-yl)-1-p-tolylhexan-1-one;MPHP
Molecular Formula:C17H25NO
Molecular Weight:259.387
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:377.0±25.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.531
PSA:
Exact Mass:259.193604
LogP:4.64
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4′-Methyl-α-pyrrolidinohexiophenone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MPHP physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(4-Methylphenyl)-2-(1-pyrrolidinyl)-1-hexanon Use and application,2-(pyrrolidin-1-yl)-1-p-tolylhexan-1-one technical grade,usp/ep/jp grade.
Related News: “His strong track record of success and deep experience of fast-moving consumer goods and consumer health, proven at P&G, Novartis and GSK, means he is the right choice” to lead the consumer health unit as an independent company, GSK Chairman Jonanthan Symonds said of McNamara in the statement. (2.2-Bis-iso-butylthiopropoxy)trimethylsilan manufacturers Over the past few years, China has been offering AstraZeneca bragging rights. But the company’s business in the country is coming to a turning point after being exposed to the government’s price-cutting scheme and local competition—and investors have caught wind. Phosphonium, trimethylphenyl-, perchlorate suppliers Grégoire Boutonnet, Chief Operating Officer of NOVA, said: “I am thrilled to be joining the NOVA team at this exciting period of growth as we launch the Jinkō platform towards wider adoption in the clinical trial development space. 1-methyl-3,3a,5,10b-tetrahydro-1H-[1,3]dioxolo[4,5-g]pyrrolo[3,2-c]quinoline-2,4-dione vendor & factory.